DataVXJournal of Nanoparticle ResearchPaper
journal article·2026-01

DoE-driven development, characterisation, in-silico ADME, and evaluation of surface functionalized SPIONs for enhanced blood–brain barrier permeability and targeted delivery of S-adenosylmethionine

Nishabh Kushwaha, Asha Patel, Kshitija Akarte, Nutan Shukla, Zhengyou Li, Shruti Patel, Viral Patel, Drishti Panjwani, Mange Ram Yadav, Anand Joshi

Journal of Nanoparticle Research· Volume 28· Issue 1
Publisher page
Bibliographic record

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Barrier Structure and Function Studies · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (60)

Show source-provided references
1. Liu E, Zhang Y, Wang JZ (2024) Updates in Alzheimer’s disease: from basic research to diagnosis and therapies. Transl Neurodegener 13:45. https://doi.org/10.1186/s40035-024-00432-x10.1186/s40035-024-00432-x ↗
2. Kushwaha N, Panjwani D, Akarte K, Patel S, Ahlawat P, Kesarla R et al (2025) Targeted delivery modalities in combination with biofunctionalized metallic nanoparticles (MNPs): combating amyloid plaques. CNANO 8:21. https://doi.org/10.2174/011573413736181725032507165410.2174/0115734137361817250325071654 ↗
3. Gao J, Cahill CM, Huang X, Roffman JL, Lamon-Fava S, Fava M et al (2018) S-adenosyl methionine and transmethylation pathways in neuropsychiatric diseases throughout life. Neurotherapeutics 15(1):156–175. https://doi.org/10.1007/s13311-017-0593-010.1007/s13311-017-0593-0 ↗
4. Lin WZ, Yu D, Xiong LY, Zebarth J, Wang R, Fischer CE et al (2025) Homocysteine, neurodegenerative biomarkers, and APOE ε4 in neurodegenerative diseases. Alzheimers Dement. https://doi.org/10.1002/alz.1437610.1002/alz.14376 ↗
5. Fuso A, Nicolia V, Ricceri L, Cavallaro RA, Isopi E, Mangia F et al (2012) S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice. Neurobiol Aging 33(7):1482.e1-1482.e16. https://doi.org/10.1016/j.neurobiolaging.2011.12.01310.1016/j.neurobiolaging.2011.12.013 ↗
6. Lombardo SM, Schneider M, Türeli AE, Günday TN (2020) Key for crossing the BBB with nanoparticles: the rational design. Beilstein J Nanotechnol 4(11):866–883. https://doi.org/10.3762/bjnano.11.7210.3762/bjnano.11.72 ↗
7. Guigou C, Lalande A, Millot N, Belharet K, Bozorg GA (2021) Use of super paramagnetic iron oxide nanoparticles as drug carriers in brain and ear: state of the art and challenges. Brain Sci 11(3):358. https://doi.org/10.3390/brainsci1103035810.3390/brainsci11030358 ↗
8. Kushwaha N, Panjwani D, Patel S, Ahlawat P, Yadav MR, Patel AS (2025) Emerging advances in nano-biomaterial assisted amyloid beta chimeric antigen receptor macrophages (CAR-M) therapy: reducing plaque burden in Alzheimer’s disease. J Drug Target 33(2):185–205. https://doi.org/10.1080/1061186X.2024.241701210.1080/1061186X.2024.2417012 ↗
9. Shabestari Khiabani S, Farshbaf M, Akbarzadeh A et al (2016) Magnetic nanoparticles: preparation methods, applications in cancer diagnosis and cancer therapy. Artif Cells Nanomed Biotechnol 45(1):6–17. https://doi.org/10.3109/21691401.2016.116770410.3109/21691401.2016.1167704 ↗
10. Nosrati R, Abnous K, Alibolandi M, Mosafer J, Dehghani S, Taghdisi SM et al (2021) Targeted SPION siderophore conjugate loaded with doxorubicin as a theranostic agent for imaging and treatment of colon carcinoma. Sci Rep 11(1):13065. https://doi.org/10.1038/s41598-021-92391-w10.1038/s41598-021-92391-w ↗
11. Rahman M (2023) Magnetic resonance imaging and iron-oxide nanoparticles in the era of personalized medicine. Nanotheranostics 7(4):424–449. https://doi.org/10.7150/ntno.8646710.7150/ntno.86467 ↗
12. Jahoushi KAA, Ayesh AI, El-Maghraby HF, Alnoush W, Higgins D, Hassan FM et al (2022) Tunable hydroxyapatite/magnetite nanohybrids with preserved magnetic properties. Adv Mater Interfaces 9(16):2102120. https://doi.org/10.1002/admi.20210212010.1002/admi.202102120 ↗
13. Zhang Y, Zhang L, Song X, Gu X, Sun H, Fu C et al (2015) Synthesis of superparamagnetic iron oxide nanoparticles modified with MPEG-PEI via photochemistry as new MRI contrast agent. J Nanomater 2015(1):417389. https://doi.org/10.1155/2015/41738910.1155/2015/417389 ↗
14. Hoang Thi TT, Nguyen Tran DH, Bach LG, Vu-Quang H, Nguyen DC, Park KD et al (2019) Functional magnetic core-shell system-based iron oxide nanoparticle coated with biocompatible copolymer for anticancer drug delivery. Pharmaceutics 11(3):120. https://doi.org/10.3390/pharmaceutics1103012010.3390/pharmaceutics11030120 ↗
15. Unterweger H, Dézsi L, Matuszak J, Janko C, Poettler M, Jordan J et al (2018) Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: evaluation of size-dependent imaging properties, storage stability and safety. IJN Volume 13:1899–1915. https://doi.org/10.2147/IJN.S15652810.2147/IJN.S156528 ↗
16. Ramzy L, Nasr M, Metwally AA, Awad GAS (2017) Cancer nanotheranostics: a review of the role of conjugated ligands for overexpressed receptors. Eur J Pharm Sci 104:273–292. https://doi.org/10.1016/j.ejps.2017.04.00510.1016/j.ejps.2017.04.005 ↗
17. Mou X, Ali Z, Li S, He N (2015) Applications of magnetic nanoparticles in targeted drug delivery system. J Nanosci Nanotechnol 15(1):54–62. https://doi.org/10.1166/jnn.2015.958510.1166/jnn.2015.9585 ↗
18. Shen Z, Wu H, Yang S, Ma X, Li Z, Tan M et al (2015) A novel trojan-horse targeting strategy to reduce the non-specific uptake of nanocarriers by non-cancerous cells. Biomaterials 70:1–11. https://doi.org/10.1016/j.biomaterials.2015.08.02210.1016/j.biomaterials.2015.08.022 ↗
19. Nabavinia M, Beltran-Huarac J (2020) Recent progress in iron oxide nanoparticles as therapeutic magnetic agents for cancer treatment and tissue engineering. ACS Appl Bio Mater 3(12):8172–8187. https://doi.org/10.1021/acsabm.0c0094710.1021/acsabm.0c00947 ↗
20. Pant A, Singh G, Barnwal RP, Sharma T, Singh B (2024) QbD-driven development and characterization of superparamagnetic iron oxide nanoparticles (SPIONS) of a bone-targeting peptide for early detection of osteoporosis. Int J Pharm 654:123936. https://doi.org/10.1016/j.ijpharm.2024.12393610.1016/j.ijpharm.2024.123936 ↗
21. Jia N, Wu H, Duan J, Wei C, Wang K, Zhang Y et al (2019) Polyethyleneimine-coated iron oxide nanoparticles as a vehicle for the delivery of small interfering RNA to macrophages in vitro and in vivo. JoVE 144:58660. https://doi.org/10.3791/58660-v10.3791/58660-v ↗
22. Schulze F, Dienelt A, Geissler S, Zaslansky P, Schoon J, Henzler K et al (2014) Amino-polyvinyl alcohol coated superparamagnetic iron oxide nanoparticles are suitable for monitoring of human mesenchymal stromal cells in vivo. Small 10(21):4340–4351. https://doi.org/10.1002/smll.20140070710.1002/smll.201400707 ↗
23. Sanati M, Aminyavari S, Khodagholi F, Hajipour MJ, Sadeghi P, Noruzi M et al (2021) PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) ameliorate learning and memory deficit in a rat model of Alzheimer’s disease: potential participation of STIMs. Neurotoxicology 85:145–159. https://doi.org/10.1016/j.neuro.2021.05.01310.1016/j.neuro.2021.05.013 ↗
24. Aliebrahimi S, Farnoudian-Habibi A, Heidari F, Amani A, Montazeri V, Sabz Andam S et al (2024) Using chitosan-coated magnetite nanoparticles as a drug carrier for opioid delivery against breast cancer. Pharm Dev Technol 2(6):596–603. https://doi.org/10.1080/10837450.2024.237256810.1080/10837450.2024.2372568 ↗
25. Khalkhali M, Rostamizadeh K, Sadighian S, Khoeini F, Naghibi M, Hamidi M (2015) The impact of polymer coatings on magnetite nanoparticles performance as MRI contrast agents: a comparative study. DARU J Pharm Sci 23(1):45. https://doi.org/10.1186/s40199-015-0124-710.1186/s40199-015-0124-7 ↗
26. Meisel CL, Bainbridge P, Mulkern RV, Mitsouras D, Wong JY (2020) Assessment of superparamagnetic iron oxide nanoparticle poly(ethylene glycol) coatings on magnetic resonance relaxation for early disease detection. IEEE Open J Eng Med Biol 1:116–122. https://doi.org/10.1109/OJEMB.2020.298946810.1109/OJEMB.2020.2989468 ↗
27. Li C, Zhou L, Yin X (2024) Pathophysiological aspects of transferrin-A potential nano-based drug delivery signaling molecule in therapeutic target for varied diseases. Front Pharmacol 15:1342181. https://doi.org/10.3389/fphar.2024.134218110.3389/fphar.2024.1342181 ↗
28. Liu S, Jin X, Ge Y, Dong J, Liu X, Pei X et al (2025) Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood–brain barrier permeability. J Nanobiotechnol 23(1):382. https://doi.org/10.1186/s12951-025-03415-w10.1186/s12951-025-03415-w ↗
29. Xu W, Xu M, Xiao Y, Yu L, Xie H, Jiang X et al (2022) Changes in target ability of nanoparticles due to protein corona composition and disease state. Asian J Pharm Sci 17(3):401–411. https://doi.org/10.1016/j.ajps.2022.03.00210.1016/j.ajps.2022.03.002 ↗
30. Ergin AD, Bayindir ZS, Gumustas M, Ozcelikay AT, Yuksel N (2025) A new strategy for enhancing S-adenosyl-L-methionine (SAMe) oral bioavailability: preparation of SAMe loaded inulin nanoparticles for colon targeting with in vivo validation. Int J Biol Macromol 289:138818. https://doi.org/10.1016/j.ijbiomac.2024.13881810.1016/j.ijbiomac.2024.138818 ↗
31. Lam T, Avti P, Pouliot P, Maafi F, Tardif JC, Rhéaume É et al (2016) Fabricating water dispersible superparamagnetic iron oxide nanoparticles for biomedical applications through ligand exchange and direct conjugation. Nanomaterials 6(6):100. https://doi.org/10.3390/nano606010010.3390/nano6060100 ↗
32. Lin MM, Li S, Kim HH, Kim H, Lee HB, Muhammed M et al (2010) Complete separation of magnetic nanoparticles via chemical cleavage of dextran by ethylenediamine for intracellular uptake. J Mater Chem 20(3):444–447. https://doi.org/10.1039/B918416C10.1039/B918416C ↗
33. Mu K, Zhang S, Ai T, Jiang J, Yao Y, Jiang L et al (2015) Monoclonal antibody–conjugated superparamagnetic iron oxide nanoparticles for imaging of epidermal growth factor receptor–targeted cells and gliomas. Mol Imaging. https://doi.org/10.2310/7290.2015.0000210.2310/7290.2015.00002 ↗
34. Jiang W, Xie H, Ghoorah D, Shang Y, Shi H, Liu F et al (2012) Conjugation of functionalized SPIONs with transferrin for targeting and imaging brain glial tumors in rat model. PLoS One 7(5):e37376. https://doi.org/10.1371/journal.pone.003737610.1371/journal.pone.0037376 ↗
35. Daina A, Michielin O, Zoete V (2019) SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47(W1):W357–W364. https://doi.org/10.1093/nar/gkz38210.1093/nar/gkz382 ↗
36. Upadhayay P, Sinha SK, Kumar N, Singh SK, Jain P, Panchawat S et al (2025) Identification of therapeutic potential of hydroxychavicol against Alzheimer’s disease: an integrated network pharmacology, molecular docking, and dynamic simulation study. J Aging Res 2025(1):7062203. https://doi.org/10.1155/jare/706220310.1155/jare/7062203 ↗
37. Ansari SR, Suárez-López YDC, Thersleff T, Häggström L, Ericsson T, Katsaros I et al (2024) Pharmaceutical quality by design approach to develop high-performance nanoparticles for magnetic hyperthermia. ACS Nano 18(23):15284–15302. https://doi.org/10.1021/acsnano.4c0468510.1021/acsnano.4c04685 ↗
38. Harman CLG, Mac Fhionnlaoich N, King AM, Manning JRH, Lin W, Scholes P et al (2022) Controlled synthesis of SPION@SiO2 nanoparticles using design of experiments. Mater Adv 3(14):6007–6018. https://doi.org/10.1039/d2ma00369d10.1039/d2ma00369d ↗
39. Wulandari AD, Sutriyo S, Rahmasari R (2022) Synthesis conditions and characterization of superparamagnetic iron oxide nanoparticles with oleic acid stabilizer. J Adv Pharm Technol Res 13(2):89–94. https://doi.org/10.4103/japtr.japtr_246_2110.4103/japtr.japtr_246_21 ↗
40. Asad S, Ahl D, Suárez-López YDC, Erdélyi M, Phillipson M, Teleki A (2025) Click chemistry-based bioconjugation of iron oxide nanoparticles. Small 21(11):2407883. https://doi.org/10.1002/smll.20240788310.1002/smll.202407883 ↗
41. Martins C, Rolo C, Cacho VRG, Pereira LCJ, Borges JP, Silva JC et al (2025) Enhancing the magnetic properties of superparamagnetic iron oxide nanoparticles using hydrothermal treatment for magnetic hyperthermia application. Mater Adv 6(5):1726–1743. https://doi.org/10.1039/D4MA01120A10.1039/D4MA01120A ↗
42. Meerod S, Tumcharern G, Wichai U, Rutnakornpituk M (2008) Magnetite nanoparticles stabilized with polymeric bilayer of poly(ethylene glycol) methyl ether–poly(ɛ-caprolactone) copolymers. Polymer 49(18):3950–3956. https://doi.org/10.1016/j.polymer.2008.07.00310.1016/j.polymer.2008.07.003 ↗
43. Khoee S, Kavand A (2014) A new procedure for preparation of polyethylene glycol-grafted magnetic iron oxide nanoparticles. J Nanostruct Chem 4(3):111. https://doi.org/10.1007/s40097-014-0111-410.1007/s40097-014-0111-4 ↗
44. Sovago M, Buis EJ, Sandtke M (2013) Nanoparticle detection in aqueous solutions using Raman and laser induced breakdown spectroscopy. Spectrochim Acta B At Spectrosc 87:182–187. https://doi.org/10.1016/j.sab.2013.05.03310.1016/j.sab.2013.05.033 ↗
45. Jelen Ž, Kovač J, Rudolf R (2023) Study of gold nanoparticles conjugated with SARS-CoV-2 S1 spike protein fragments. Nanomaterials 13(15):2160. https://doi.org/10.3390/nano1315216010.3390/nano13152160 ↗
46. Heu R, Shahbazmohamadi S, Yorston J, Capeder P (2019) Target material selection for sputter coating of SEM samples. Micros Today 27(4):32–36. https://doi.org/10.1017/S155192951900061010.1017/S1551929519000610 ↗
47. Marguí E, Queralt I, De Almeida E (2022) X-ray fluorescence spectrometry for environmental analysis: basic principles, instrumentation, applications and recent trends. Chemosphere 303:135006. https://doi.org/10.1016/j.chemosphere.2022.13500610.1016/j.chemosphere.2022.135006 ↗
48. Pushie MJ, Pickering IJ, Korbas M, Hackett MJ, George GN (2014) Elemental and chemically specific X-ray fluorescence imaging of biological systems. Chem Rev 114(17):8499–8541. https://doi.org/10.1021/cr400729710.1021/cr4007297 ↗
49. Chaulagain B, Gothwal A, Lamptey RNL, Trivedi R, Mahanta AK, Layek B et al (2023) Experimental models of in vitro blood–brain barrier for CNS drug delivery: an evolutionary perspective. IJMS 24(3):2710. https://doi.org/10.3390/ijms2403271010.3390/ijms24032710 ↗
50. Sakurai H, L. Carpenter L, R. Tyrka A, Price LH, I. Papakostas G, Dording CM et al (2020) Dose increase of S-adenosyl-methionine and escitalopram in a randomized clinical trial for major depressive disorder. J Affect Disord 262:118–125. https://doi.org/10.1016/j.jad.2019.10.04010.1016/j.jad.2019.10.040 ↗
51. Fernandes YM, Rampersad M, Luchiari AC, Gerlai R (2016) Associative learning in the multichamber tank: a new learning paradigm for zebrafish. Behav Brain Res 312:279–284. https://doi.org/10.1016/j.bbr.2016.06.03810.1016/j.bbr.2016.06.038 ↗
52. Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y (2023) The blood–brain barrier: structure, regulation and drug delivery. Sig Transduct Target Ther 8(1):217. https://doi.org/10.1038/s41392-023-01481-w10.1038/s41392-023-01481-w ↗
53. Johnsen KB, Burkhart A, Thomsen LB, Andresen TL, Moos T (2019) Targeting the transferrin receptor for brain drug delivery. Prog Neurobiol 181:101665. https://doi.org/10.1016/j.pneurobio.2019.10166510.1016/j.pneurobio.2019.101665 ↗
54. Thomsen MS, Johnsen KB, Kucharz K, Lauritzen M, Moos T (2022) Blood–brain barrier transport of transferrin receptor-targeted nanoparticles. Pharmaceutics 14(10):2237. https://doi.org/10.3390/pharmaceutics1410223710.3390/pharmaceutics14102237 ↗
55. Shireby G, Dempster EL, Policicchio S, Smith RG, Pishva E, Chioza B et al (2022) DNA methylation signatures of Alzheimer’s disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types. Nat Commun 13(1):5620. https://doi.org/10.1038/s41467-022-33394-710.1038/s41467-022-33394-7 ↗
56. Balmik AA, Chinnathambi S (2021) Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease. Cell Commun Signal 19(1):51. https://doi.org/10.1186/s12964-021-00732-z10.1186/s12964-021-00732-z ↗
57. Holper S, Watson R, Churilov L, Yates P, Lim YY, Barnham KJ et al (2023) Protocol of a phase II randomized, multi-center, double-blind, placebo-controlled trial of S-adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer’s disease. J Prev Alzheimers Dis 10(4):800–809. https://doi.org/10.14283/jpad.2023.5510.14283/jpad.2023.55 ↗
58. Koneru T, McCord E, Pawar S, Tatiparti K, Sau S, Iyer AK (2021) Transferrin: biology and use in receptor-targeted nanotherapy of gliomas. ACS Omega 6(6):8727–8733. https://doi.org/10.1021/acsomega.0c0584810.1021/acsomega.0c05848 ↗
59. Alves VC, Carro E, Figueiro-Silva J (2024) Unveiling DNA methylation in Alzheimer’s disease: a review of array-based human brain studies. Neural Regen Res 19(11):2365–2376. https://doi.org/10.4103/1673-5374.39310610.4103/1673-5374.393106 ↗
60. Alzheimer’s Drug Discovery Foundation. (n.d.). S-adenosylmethionine (SAMe) evidence summary. Cognitive Vitality Reports®. Retrieved from https://www.alzdiscovery.org/uploads/cognitive_vitality_media/S-Adenosylmethionine-Cognitive-Vitality-For-Researchers.pdf. Accessed 20 September 2025